Market Cap
₹1,242 Cr.
P/E
69.96
About
Gulshan Polyols Limited is India’s leading manufacturers of Ethanol/Bio-fuel, Grain and Mineral based specialty products with three decades of experience. Its business portfolio broadly spans across t… Read more
Gulshan Polyols Limited is India’s leading manufacturers of Ethanol/Bio-fuel, Grain and Minera… Read more
Low
158
52W Range
High
242
Quick View
  • 1d
  • 1m
  • 6m
  • YTD
  • 1y
  • 3y
  • 5y
  • 10y
  • max

Company Timeline

Forensics

9 Yes

Positive for this company

0 Neutral

Neutral for this company

8 No

Negative for this company

0 No Data

Insufficient data to analyse

ROE
Latest
7.86%
3yr Average
13.43%
5yr Average
10.88%
Net Profit Margin
Latest
3.83%
3yr Average
6.56%
5yr Average
5.24%
ROCE
Latest
9.2%
3yr Average
18.03%
5yr Average
15.69%
Debt to Equity
Latest
0.43
3yr Average
0.22
5yr Average
0.3
Revenue mix

Product Wise Break-Up

Segment Break-Up

Location Wise Break-Up

Operating Profit Break-Up

Raw Material Break-Up

Asset Break-Up

Peer Comparison
Customers
  • Asian Paints Ltd.
  • Astrazeneca Pharma India Ltd.
  • BASF India Ltd.
  • Britannia Industries Ltd.
  • Zydus Lifesciences Ltd.
FAQs on Gulshan Polyols Ltd. Business

Gulshan Polyols Limited is a leading Indian manufacturer with 30 years of experience producing specialty products like starch, sorbitol, calcium carbonate, and ethanol through its grain processing, bio-fuel/distillery, and mineral processing operations.

Gulshan Polyols major competitors are Sukhjit Starch &Chem, Sayaji Industries, Guj. Ambuja Exports, Saint-Gobain Sekurit, Kamdhenu Ventures, Meson Valves India, RACL Geartech.
Market Cap of Gulshan Polyols is ₹1,242 Crs.
While the median market cap of its peers are ₹1,240 Crs.

Gulshan Polyols seems to be less financially stable compared to its peers.
Altman Z score of Gulshan Polyols is 4.12 and is ranked 6 out of its 8 competitors.

Company Filing
2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
Annual Report FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
Earnings Release Mar Jun Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec
Investor Presentation Mar Jun Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec
Conference Call Mar Jun Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec
Conference Call SummaryCon Call Summary Mar Jun Mar Jun Sep Dec Mar Jun Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec
Discussions & Analysis